Key facts
- This page summarizes Stephen Basil Thomas's Form 4 filing for Climb Bio, Inc. (CLYM).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 11 Aug 2025, 16:15.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Award
Additional SEC filing notes
Footnote F1
On June 27, 2024, the reporting person was granted restricted stock units ("RSUs") to acquire a total of 100,375 shares of common stock that vested based on the achievement of certain performance-based milestones and subject to continuous service. On August 7, 2025, the milestones were deemed to be achieved, resulting in the vesting of the RSUs as to all 100,375 shares.